Desipramine Completed Phase 4 Trials for Depression Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00320632Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression